Swiss imported electrochemical nitric oxide asthma diagnostic sensor

This model of sensor has high accuracy, with a resolution of up to 2ppm; The product has stable performance, good consistency, and good repeatability; Can be used under low temperature conditions. Features: Small size, fast detection speed, high accuracy.

Breath diagnosis, also known as breath test, refers to the direct measurement of breath components or the detection and analysis of characteristic gas components or physical and chemical properties such as flow rate, flow rate, acidity and alkalinity in breath after ingestion of specific compounds, in order to achieve non-invasive diagnosis of some diseases.

The respiratory diagnostics currently approved by the FDA include detection of ethanol concentration in exhaled breath, detection of hydrogen in exhaled breath, 13C urea breath test, detection of nitric oxide concentration in exhaled breath, etc. Breath diagnosis is an emerging in vitro diagnostic technology. Since the 21st century, the number of research papers on breath diagnosis worldwide has been increasing year by year. With the continuous deepening of research, the application scope of breath diagnosis in clinical practice has gradually expanded, involving respiratory function testing, asthma testing, Helicobacter pylori testing, cancer testing, inflammation testing and other aspects.

In recent years, companies from multiple countries around the world have been actively expanding into the breath diagnosis market. Domestically, attracted by the market prospects, the number of enterprises that have laid out breath diagnosis in China is constantly increasing.

According to the "2021-2025 Global Breath Diagnosis Industry Deep Market Research and Key Regional Research Report", breath diagnosis has been widely used in clinical practice. In 2019, the breath diagnosis market in China exceeded 2.4 billion yuan, with urea breath diagnosis accounting for a relatively high proportion.

Driven by the epidemic, the demand for breath diagnosis market continues to rise, and the development speed of the breath diagnosis market is accelerating. Overall, the global breath diagnosis market has a relatively short development time, and most of the segmented breath diagnosis markets are still in the incubation period. However, with continuous breakthroughs in related technologies and the release of market demand, the potential for future development of the respiratory diagnosis market is promising.

Shenzhen Fuanda Intelligent Technology Co., Ltd. specializes in providing breath diagnostic medical sensors and application development solutions. Recommended products,NO/CFL-1-4ETheCO/CF-200-4ETheH2/CA-1000TheH2S/CG-100-4EWait.